Omeros | OMER - Loan Capital


Omeros reported $403.72M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Adma Biologics USD 192.84M 745K Jun/2026
Alnylam Pharmaceuticals USD 2.47B 6.56M Jun/2026
BioMarin Pharmaceutical USD 3.53B 2.1B Jun/2026
Cytokinetics USD 248.2M 993K Jun/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
Heron Therapeutics USD 140.64M 975K Dec/2025
Immunic USD 0 0 Jun/2024
Insmed USD 543.51M 1.3M Jun/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
MacroGenics USD 68.71M 1.29M Mar/2026
Omeros USD 403.72M 27.2M Jun/2024
Pacira USD 363.12M 4.53M Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Rockwell Medical USD 8.65M 89K Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 847.62M 9.46M Jun/2026
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025